78 related articles for article (PubMed ID: 1099318)
1. Adsorbent hemoperfusion: nonbiological particulate matter.
Van Wagenen R; Coleman DL; Andrade JD
Kidney Int Suppl; 1975 Feb; (3):397-400. PubMed ID: 1099318
[No Abstract] [Full Text] [Related]
2. Evaluation and selection of activated carbon for hemoperfusion.
Walker JM; Denti E; Van Wagenen R; Andrade JD
Kidney Int Suppl; 1976 Dec; (7):S320-7. PubMed ID: 1070555
[No Abstract] [Full Text] [Related]
3. Sorbent augmented dialysis: minor addition or major advance in therapy?
Winchester JF; Ronco C; Brady JA; Golds E; Clemmer J; Cowgill LD; Muller TE; Levin NW
Blood Purif; 2001; 19(2):255-9. PubMed ID: 11150820
[No Abstract] [Full Text] [Related]
4. Preparation of spherical encapsulation of activated carbons and their adsorption capacity of typical uremic toxins.
Lee CJ; Hsu ST
J Biomed Mater Res; 1990 Feb; 24(2):243-58. PubMed ID: 2329118
[TBL] [Abstract][Full Text] [Related]
5. [The significance of the regeneration of dialysate using carbon adsorption in uremia and various intoxications].
van Leer E
Ned Tijdschr Geneeskd; 1970 Nov; 114(46):1940-2. PubMed ID: 5475267
[No Abstract] [Full Text] [Related]
6. Active carbon and its controversial ability to adsorb uremic toxins.
Giordano C; Esposito R; Cirillo D; Betuel H; Fredel A; Pluvio M; Mazzola G; Longhi R; Manzo M
Int J Artif Organs; 1984 Jul; 7(4):177-80. PubMed ID: 6490189
[No Abstract] [Full Text] [Related]
7. Combined haemoabsorption-haemodialysis (HA-HD) treatment in chronic uraemia.
Barboutis K; Sakellariou G; Vergoulas G; Vyzantiadis A; Kalpakoglou S; Papadimitriou M
Life Support Syst; 1985; 3 Suppl 1():45-52. PubMed ID: 3916615
[No Abstract] [Full Text] [Related]
8. [Lipid metabolism in hemofiltration. Comparison with the lipid pattern of hemodialyzed patients].
Civati G; Galato R; Franceschini G; Guastoni C; Perego A; Minetti L
Minerva Nefrol; 1980; 27(4):669-74. PubMed ID: 7254694
[No Abstract] [Full Text] [Related]
9. Gastrosorbents in the therapy of uremia: inferences from intestinal loop dialysis.
Sparks RE
Kidney Int Suppl; 1975 Feb; (3):373-6. PubMed ID: 1099316
[No Abstract] [Full Text] [Related]
10. [Adsorption in the treatment of uremia].
Botella-García J
Nefrologia; 2000; 20(3):197-201. PubMed ID: 10916996
[No Abstract] [Full Text] [Related]
11. [Effect of hemoperfusion on various blood coagulation and fibrinolysis factors in chronic uremia].
Lewicki R; Trznadel K; Luciak M; Kidawa Z
Pol Tyg Lek; 1981 Aug; 36(35):1325-7. PubMed ID: 7329845
[No Abstract] [Full Text] [Related]
12. Hemoperfusion for uremia: past, present, and future.
Winchester JF; Ash SR
Kidney Int Suppl; 1985 Dec; 17():S127-30. PubMed ID: 3867782
[No Abstract] [Full Text] [Related]
13. Letter: Particulate matter in Ancef and Kefzol.
Turco SJ; Davis NM; Bhatia R
Am J Hosp Pharm; 1974 Mar; 31(3):222 passim. PubMed ID: 4819435
[No Abstract] [Full Text] [Related]
14. The effects of carbon hemoperfusion and hemodialysis on fibrinolysis.
Martin AM; Gibbins JK; Jones WT; Smith C
Trans Am Soc Artif Intern Organs; 1980; 26():142-3. PubMed ID: 7245471
[No Abstract] [Full Text] [Related]
15. Removal of methylene blue from wastewater using fly ash as an adsorbent by hydrocyclone.
Rastogi K; Sahu JN; Meikap BC; Biswas MN
J Hazard Mater; 2008 Oct; 158(2-3):531-40. PubMed ID: 18339480
[TBL] [Abstract][Full Text] [Related]
16. Particulate matter in commercial antibiotic injectable products.
Masuda JY; Beckerman JH
Am J Hosp Pharm; 1973 Jan; 30(1):72-6. PubMed ID: 4687051
[No Abstract] [Full Text] [Related]
17. Removal of waste metabolites in uremia by microencapsulated reactants.
Sparks RE; Salemme RM; Meier PM; Litt MH; Lindan O
Trans Am Soc Artif Intern Organs; 1969; 15():353-9. PubMed ID: 5791409
[No Abstract] [Full Text] [Related]
18. Adsorption of the uremic toxin p-cresol onto hemodialysis membranes and microporous adsorbent zeolite silicalite.
Wernert V; Schäf O; Faure V; Brunet P; Dou L; Berland Y; Boulet P; Kuchta B; Denoyel R
J Biotechnol; 2006 May; 123(2):164-73. PubMed ID: 16388867
[TBL] [Abstract][Full Text] [Related]
19. Personal respiratory protective devices: efficacy of intranasal stent with filters.
Tanpowpong K
J Med Assoc Thai; 2000 Jan; 83(1):21-7. PubMed ID: 10710865
[TBL] [Abstract][Full Text] [Related]
20. [New dialysis strategies. Effect on acid-base equilibrium, pO2 and pCO2].
Mastrangelo F; Rizzelli S; Lopez T; Manisco G; Corlianò C; Alfonso L
Minerva Nefrol; 1975; 22(4-5):188-92. PubMed ID: 1207976
[No Abstract] [Full Text] [Related]
[Next] [New Search]
